Stamford, CT -- (SBWIRE) -- 01/28/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Chromadex Corp (OTCMKTS:CDXC), VESTAS WIND ADR (OTCMKTS:VWDRY), La Jolla Pharmaceutical Company (OTCBB:LJPCD), TITAN MEDICAL INC (OTCMKTS:TITXF)
Chromadex Corp (OTCMKTS:CDXC) opened the session at $1.73, trading in a range of $1.42 - $1.73. The stock showed a negative performance of -7.34% in the last trading session from its previous close of $1.77 and closed at $1.64. The stock traded on a volume of 393,960 shares and the average volume of the stock remained 244,190 shares. Chromadex Corporation is a provider of research and quality-control products and services to the natural products industry. The Company’s products are used by customers worldwide in the dietary supplement, food and beverage, cosmetic and pharmaceutical industries. The Company together with its subsidiaries supplies phytochemical reference standards, which are small quantities of plant-based compounds used to research an array of potential attributes, and reference materials, related contract services, technical consulting and ingredients.
Has CDXC Found The Bottom and Ready To Move Up? Find Out Here
VESTAS WIND ADR (OTCMKTS:VWDRY) traded 263,491 shares in the last business day while the average volume of the stock remained 48,374 shares. The stock showed a negative movement of -6.45% to end at $10.01. The 52 week range of the stock remained $1.95 - $12.00. Vestas Wind Systems A/S engages in the manufacture and sale of wind turbines and wind power systems worldwide. It also offers wind project planning, procurement, construction, operation, and power plant optimization services; and after sale services, as well as sells spare parts. The company was founded in 1898 and is headquartered in Aarhus N, Denmark.
Has VWDRY Found The Bottom And Ready To Gain Momentum? Find Out Here
La Jolla Pharmaceutical Company (OTCBB:LJPCD) reported 47,609 shares were exchanged during the last trade, while the average volume is about 70,153 shares. The stock dropped -6.43% and finished the day at $7.86. The beta of the stock is recorded at 1.50. La Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the development of treatments that inhibits the activity of galectins as a means of treating human diseases, such as cancer and chronic organ failure. The Company was focused on the development and testing of Riquent as a treatment for Lupus nephritis. On January 19, 2012, the Company acquired rights to certain assets, including a clinical-stage compound designated GCS-100, from Solana Therapeutics, Inc. (Solana).
Why Should Investors Buy LJPCD After the Recent Fall? Just Go Here and Find Out
TITAN MEDICAL INC (OTCMKTS:TITXF) shares dropped -6.25 percent from its previous close of $1.44 to close at $1.35. Traded with volume of 886,866 shares in the prior session and the average volume of the stock remained 195,750 shares. Titan Medical Inc., a development stage company, engages in the design and development of Amadeus robotic surgical system for application in minimally invasive surgery (MIS).
Will TITXF Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)